Loading
Modus Therapeutics Holding AB Stock: price and insider trades · Sweden
Modus Therapeutics Holding AB: what insiders have been doing
Only a handful of insider records exist for Modus Therapeutics Holding AB, the last one from 1 September 2025, too few to describe a trend. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2025FY ended December 2025 · cache
SEK 0.36
Analyst consensus
Income statement
EBITDA-SEK 18.1M
Net income-SEK 18.5M0.0% margin
Valuation
P/Book7.5x
Beta0.39
Balance sheet & cash
Market capSEK 53.4M
Free Cash Flow-SEK 18.1M
Profitability & ownership
ROE-743.9%
ROA-167.5%
% insiders76.8%
% institutions3.0%
Last declaration on 1 September 2025
Declarations1 total
4,891,533 shares@ SEK 3.1529.17% mcap100.0% of flowBTU (betald tecknad unit)ISIN SE0025667546FI:A003R901-1
1 of 1 declaration
About Modus Therapeutics Holding AB
Modus Therapeutics Holding AB is a biopharmaceutical company focused on developing treatments for chronic diseases. It is listed on the XSTO exchange.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
